Latest Asx News

Opyl Limited has secured strategic collaborations with two leading contract research organisations, integrating its AI-driven TrialKey platform into cardiovascular, oncology, and rare disease clinical trials to enhance trial design and accelerate commercial growth.

Alvo Minerals Limited has had its trading suspension lifted immediately following the release of details about its Entitlement Offer, signaling renewed market activity.

True North Copper has identified multiple high-confidence Iron Oxide Copper-Gold drill targets at its Salebury Mineral System in Queensland, signalling potential resource growth in a world-class copper province.

Melody Gold has exercised its option to process gold surface materials at Horseshoe Metals’ Horseshoe Lights project, initiating a three-year exclusive licence that promises early cash flow to accelerate copper development.

Silver Mines Limited has secured two historic Californian projects, Calico North and Kramer Hills, adding significant silver and gold exploration potential to its portfolio with minimal upfront cash outlay.

ASX Limited’s 2025 Investor Forum reveals steady progress on its five-year strategy, highlighting technology modernization, operational risk management, and a focus on data-driven growth. The exchange outlines capital expenditure plans and expense controls aimed at sustaining shareholder value amid evolving market demands.

Aguia Resources is ramping up production at its high-grade Santa Barbara gold project in Colombia while advancing a low-capital phosphate operation in Brazil, setting the stage for robust cash flow generation.

ASX Limited reveals steady progress on its FY28 strategy, emphasizing technology modernization and operational resilience while providing detailed financial guidance through FY27.

Cleo Diagnostics unveils a pioneering blood test for early ovarian cancer detection, boasting superior accuracy to existing methods and targeting a significant U.S. market opportunity.

Bioxyne Limited has raised its FY2025 revenue guidance to $28 million, driven by explosive growth in Australian pharmaceutical manufacturing and the upcoming commercial production of MDMA capsules. The company is also making strides in expanding its footprint across Europe.

Brazilian Rare Earths has successfully produced high-purity mixed-rare-earth carbonate and uranium yellowcake from its Monte Alto Project, marking a key milestone in its integrated supply chain ambitions.

L1 Capital and its associates, holding nearly 17% of Platinum Capital, oppose the proposed restructure into an ETF, while the Board urges shareholders to approve the scheme.